Neuman M, Fluteau G
Chemotherapy. 1977;23 Suppl 1:196-9. doi: 10.1159/000222047.
The following parameters were considered in studying 43 subjects under treatment for urinary infections with different degrees of renal insufficiency: the maximum blood concentrations, the plasmatic half-life, and the urinary concentrations of fosfomycin as a function of the plasma creatinine of the subject treated. The curve of the average maximum blood concentrations show a parabola-like increase, the plasmatic half-life followed the same tendency, while the curve of the average urinary concentrations presented an exponential decrease. The urinary concentrations were, nevertheless, always higher than 100 mug/ml regardless of the degree of renal insufficiency and even in the subjects who had a very high plasma creatinine. Given its absence of renal and systemic toxicity, the daily dosage of fosfomycin could remain unchanged regardless of the degree of insufficiency.
在对43例患有不同程度肾功能不全且正在接受尿路感染治疗的受试者进行研究时,考虑了以下参数:最大血药浓度、血浆半衰期以及磷霉素的尿药浓度与接受治疗受试者的血浆肌酐的关系。平均最大血药浓度曲线呈抛物线状上升,血浆半衰期呈现相同趋势,而平均尿药浓度曲线呈指数下降。然而,无论肾功能不全程度如何,甚至在血浆肌酐非常高的受试者中,尿药浓度始终高于100μg/ml。鉴于磷霉素无肾毒性和全身毒性,无论肾功能不全程度如何,磷霉素的每日剂量均可保持不变。